[13C]-galactose breath test in a patient with galactokinase deficiency and spastic diparesis.
Can FiciciogluDidem DemirbasBritt DerksG Shashidhar PaiDavid J TimsonMaria Estela Rubio-GozalboGerard T BerryPublished in: JIMD reports (2021)
Galactokinase deficiency is an inborn error of carbohydrate metabolism due to a block in the formation of galactose-1-phosphate from galactose. Although the association of galactokinase deficiency with formation of cataracts is well established, the extent of the clinical phenotype is still under investigation. We describe a 6-year-old female who was diagnosed with galactokinase deficiency due to cataract formation when she was 10 months of age and initially started on galactose-restricted diet at that time for 5 months. She developed gait abnormality at 4 years of age. Breath tests via measurement of 13C isotope in exhaled carbon dioxide following 13C-labeled galactose administration at carbon-1 and carbon-2 positions revealed oxidation rates within the normal range. The results in this patient strikingly contrast with the results of another patient with GALK1 deficiency that underwent breath testing with [1-14C]-galactose and [2-14C]-galactose. Extension of in vivo breath tests to other galactokinase patients is needed to better understand the pathophysiology of this disease.
Keyphrases
- case report
- carbon dioxide
- replacement therapy
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- magnetic resonance imaging
- computed tomography
- high resolution
- weight loss
- hydrogen peroxide
- nitric oxide
- positron emission tomography
- smoking cessation
- simultaneous determination